Xvivo Perfusion Aktiebolag
XVIVO SE0004840718
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-15% | -22% | 56% | 52% | -2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Christoffer Björn Rosenblad CEO |
197.00 SEK |
2,000 Bought |
394,000 SEK |
29/07/2025 | 29/07/2025 |
Camilla öberg DIR |
213.20 SEK |
703 Bought |
149,880 SEK |
14/07/2025 | 14/07/2025 |
Kristoffer Nordström CFO |
214.00 SEK |
20 Bought |
4,280 SEK |
14/07/2025 | 14/07/2025 |
Kristoffer Nordström CFO |
227.80 SEK |
85 Bought |
19,363 SEK |
14/07/2025 | 11/07/2025 |
Gösta Johannesson CB |
219.00 SEK |
1,000 Bought |
219,000 SEK |
13/07/2025 | 11/07/2025 |
Kristoffer Nordström CFO |
226.40 SEK |
95 Bought |
21,508 SEK |
14/07/2025 | 11/07/2025 |
Gösta Johannesson CB |
314.00 SEK |
1,000 Bought |
314,000 SEK |
12/05/2025 | 12/05/2025 |
Lena Hagman VP |
311.00 SEK |
1,500 Bought |
466,500 SEK |
28/04/2025 | 28/04/2025 |
Christoffer Björn Rosenblad CEO |
457.50 SEK |
2,000 Sold |
915,000 SEK |
25/11/2024 | 25/11/2024 |
Christoffer Björn Rosenblad CEO |
457.00 SEK |
100 Sold |
45,700 SEK |
21/11/2024 | 20/11/2024 |